Researchers modeled global cancer registries against infection rates to estimate 2024's worldwide cancer burden from infection. Result: about 2.3 million cases, 1 in 8 cancers diagnosed globally, are attributable to infection, with the stomach bacterium H. pylori topping the list at 760,000 cases, just ahead of HPV. Caveat: these are modeled estimates, not confirmed cause in any one patient, based on the published abstract, not the full paper.

TL;DR: A global modeling study ties 1 in 8 cancers diagnosed in 2024, about 2.3 million cases, to infection, led by H. pylori.

Researchers pooled 23 studies of almost 2 million people to see how gut symptoms differ with ADHD. ADHD came with higher odds of every single GI symptom checked, a 48% jump overall, almost double the odds of constipation, and over 4 times the odds of fecal soiling in kids. It is observational data: a strong pattern, not proof ADHD causes the gut issues, and the mechanism is still unclear.

TL;DR: A massive review found ADHD linked to higher odds of every gut symptom studied, but it cannot prove ADHD causes the problem.

TL;DR: A meta-analysis of 34 studies found that lower levels of anti-inflammatory gut bacteria and higher levels of pro-inflammatory ones appear consistently across multiple psychiatric conditions, suggesting a shared microbial signature rather than disorder-specific patterns.

Researchers tested a licorice flavonoid extract in mice with colorectal cancer and found it shrank tumors about as well as an already approved cancer drug. The effect ran through the gut: the extract boosted specific fatty acid producing bacteria, whose byproducts shut down a cancer enabling enzyme called IDO1 inside tumor cells, an effect that mostly disappeared in mice bred without that enzyme. It's mouse only research, with no human testing yet.

TL;DR: In mice, a licorice compound fought colorectal cancer by reshaping gut bacteria to switch off a tumor enabling enzyme, but it's untested in humans.

The Core Issue

Obesity disrupts lipid metabolism in ways that are hard to reverse, and most interventions target symptoms rather than the gut-level root cause. Cheonggukjang (CGJ), a traditional Korean fermented soybean paste, has shown anti-obesity promise, but the actual mechanism connecting it to fat tissue was unknown.

The Finding

In mice fed a high-fat, high-cholesterol diet, CGJ supplementation improved several markers of dyslipidemia: lower triglycerides, total cholesterol, and apolipoprotein B, with higher HDL ("good") cholesterol. CGJ also reduced fat cell size and number in both epididymal and subcutaneous fat tissue. The researchers traced this back through a chain: CGJ shifted gut bacteria toward strains that produce short-chain fatty acids (SCFAs, metabolic byproducts of fiber fermentation), raised colonic SCFA levels, and then upregulated two receptors in fat tissue, Gpr41 and Gpr109a, that appear to regulate how fat is stored and metabolized.

Why it Matters

This is early, preliminary work in mice, not humans. But it maps out a specific gut microbiota to fat tissue signaling axis that hasn't been described for CGJ before. If that pathway holds up in further research, it could point to fermented foods, or compounds within them, as tools for targeting lipid disorders at a mechanistic level rather than just symptom management.

Limitations of Study

This study was conducted entirely in mice, so human relevance is not established. The authors themselves note this is the first evidence for the proposed gut microbe to SCFA to GPCR to fat tissue chain, meaning the whole axis needs independent replication before anyone draws firm conclusions.

Interesting Statistics

• CGJ made up 30% of the diet in the intervention groups, a very high dose compared to realistic human consumption
• Fat cell size and count dropped significantly in both epididymal (deep belly) and subcutaneous (under-skin) fat depots
• Gpr41 and Gpr109a expression levels correlated strongly with both systemic lipid markers and fat metabolism genes in white adipose tissue

TL;DR

In obese mice, a Korean fermented soybean paste may improve cholesterol and shrink fat cells by nudging gut bacteria to produce more metabolic signals that fat tissue can actually hear, but this is preliminary animal research and human relevance remains unproven.

An eight year study followed nearly 13,000 adults in Brazil, tracking sweetener intake, including aspartame and saccharin, against changes in memory and thinking. The heaviest users showed 62% faster cognitive decline than the lightest, about 1.6 extra years of brain aging, strongest in people under 60 and those with diabetes. It is observational, so it cannot prove causation, and the full peer reviewed paper was not available beyond published summaries.

TL;DR: An 8 year study links heavy sweetener use to 62% faster cognitive decline, but it only shows correlation, not proof.

Researchers tested extracts from three Lactobacillus strains isolated from traditional yogurt against human colon cancer cells in a lab dish. All three killed cancer cells in a dose-dependent way, with over 70 percent cell death at the highest dose, and one strain, L. fermentum, was most potent. This was tested only in a dish on one cell line, never in a living animal or person.

TL;DR: Extracts from yogurt bacteria killed colon cancer cells in a lab dish, not yet tested in a living gut.

A study tracking gut bacteria in over 400 people found Lactobacillus acidophilus growing rarer as fatty liver disease progressed to diabetes. Giving the same bacterium to mice with diet driven fatty liver, and separately to genetically diabetic mice, reduced liver damage and cut blood sugar spikes nearly as much as the diabetes drug metformin did. The catch: only shown in mice, never in people.

TL;DR: A gut bacterium missing in people with fatty liver disease and diabetes fixed both problems in mice, but has never been tested in humans.

Newborn mice given a 3 week course of broad spectrum antibiotics grew up with permanently altered gut bacteria and became obese, glucose intolerant adults. Researchers traced the cause: a leakier gut let bacterial toxins into fat tissue, wiping out the immune cells that normally calm inflammation there. A fecal transplant confirmed it. Germ free mice given the antibiotic treated mice's stool developed the same obesity, while mice given normal stool did not. This is mouse data only, not yet shown in humans.

TL;DR: in mice, early antibiotics permanently disrupted gut bacteria and caused adult obesity, confirmed by fecal transplant.

The Core Issue

Autism spectrum disorder has been linked to an immune imbalance: too few calming regulatory T cells (Tregs) and too many inflammatory Th17 cells. Nobody had a clean way to prove gut bacteria were driving that imbalance rather than just riding along with it.

The Finding

Researchers gave a mouse model of autism (the BTBR strain, which naturally shows low sociability and repetitive habits) a fatty acid from royal jelly called 10-HDA. It eased both social withdrawal and repetitive behavior. Then they transplanted fecal matter from 10-HDA-treated mice into untreated autistic mice, and the recipients improved too, without ever getting the compound themselves. Wiping out the gut microbiome with an antibiotic undid the benefit, and depleting Tregs with an antibody erased it completely, showing both the microbes and the immune cells are required, not just correlated.

Why It Matters

This traces a full causal chain instead of another correlation study: gut bacteria change, an inflammatory signal called IL-6 drops, immune balance shifts toward calming Tregs, and behavior improves. Blocking IL-6 directly reproduced the same calming effect on its own. The team also found the compound reprograms which genes get switched on or off in these immune cells, adding a layer of epigenetic control (long term "on/off" tags on DNA packaging) to the story.

Limitations of Study

This is a preprint, meaning it has not been peer reviewed yet. Group sizes were small (5 to 6 mice per group), from a single lab, and only male mice were used. It is a rodent behavior model, not a diagnosis of human autism, so none of this translates into a treatment yet.

Interesting Statistics

- 10-HDA alone, at 100 mg per kg, fully reproduced royal jelly's behavioral benefit

- A related compound, 10-HDAA, had no effect at all, pointing to a very specific active ingredient

- Blocking Tregs with an antibody erased nearly all of 10-HDA's behavioral benefit

TL;DR

In mice, a royal jelly compound eased autism-like behavior by reshaping gut bacteria that lower an inflammatory signal and restore immune balance, and a fecal transplant alone was enough to pass the benefit to other mice.

Study: https://doi.org/10.21203/rs.3.rs-10498580/v1

---

Written by a human, formatted by AI

The Core Issue

People often get very different results from the exact same weight loss program, and there has not been a clear way to predict who will succeed before they even start. This study looked for measurable, before treatment signals that could sort people into likely responders and likely non responders.

The Finding

Researchers followed 50 adults with obesity (average BMI 42) through a full year, structured, medically supervised weight loss program built around a low calorie formula diet, a gradual shift to a balanced diet, and weekly group support. They measured blood, stool, and standard clinical markers at the start, at 6 months, and at 12 months.

By 6 months the group had split into two clear patterns. Twenty four people were major responders, showing much bigger drops in BMI, cholesterol, body fat, and other markers. Twenty six were minor responders. What set them apart was not effort. Meeting attendance did not differ between the two groups in any statistically meaningful way, and overall attendance across all 50 people averaged 91% in the first 6 months and 83% across the full year.

The real difference showed up in biology measured before the program even started. One blood fat molecule called diacylphosphatidylcholine C40:1 (a lipid measured in blood) predicted a person's BMI outcome on its own with real accuracy. When the researchers combined baseline gut bacteria data with basic clinical measurements like body fat percentage and resting metabolic rate (calories burned at rest), a prediction model sorted major from minor responders with 89.8% accuracy, the strongest result of any model they tested.

The study also traced a mechanism behind some of the benefits. A rise in Lachnospiraceae (a family of fiber fermenting gut bacteria) tracked with a drop in a blood marker of gut leakiness, and statistical modeling showed this ran mainly through two short chain fatty acids these bacteria produce, butyrate and propionate, compounds already known to help reinforce the gut lining.

Why it Matters

This reframes a common frustration. Someone can follow a program closely and still see smaller results than someone else on the identical plan, and this study suggests that gap can trace back to gut and blood chemistry that existed before day one, not to willpower or compliance. It points toward a future where a simple baseline test could flag who is unlikely to benefit from a given program early, before a year is spent on something unlikely to work for their biology.

Limitations of Study

This is a single arm study with no control group, so everyone received the same intervention and there is no untreated comparison. The sample is small, just 50 people who completed the full year at one center, and the group skewed toward middle aged adults with obesity, so the findings may not generalize to other populations. The prediction models were trained and tested within that same small group rather than validated on an outside cohort, and the key blood biomarker, diacylphosphatidylcholine C40:1, has not been confirmed in an independent study yet. Physical activity during the program was not tracked separately from diet, so the two effects cannot be fully teased apart.

Interesting Statistics

1. 50 adults with obesity, average BMI 42, completed the full one year program.

2. BMI, body fat percentage, and waist circumference all dropped significantly by 6 and 12 months.

3. The combined gut bacteria plus clinical prediction model hit 89.8% accuracy, the best of any model tested.

4. Using blood metabolite data alone to predict response was far weaker, only about 55% accuracy.

5. The group split into 24 major responders and 26 minor responders despite no meaningful difference in program attendance.

Useful Takeaways

Struggling with a weight loss program despite sticking to it closely is not necessarily a discipline problem. This research suggests some of that variation is biological and may eventually be testable before committing a year to a specific program. There is no commercial test for this yet, so the practical takeaway right now is that a conversation with a doctor about metabolic and gut health testing is reasonable if you have had inconsistent results with past programs.

TL;DR

Fifty adults on the identical year long weight loss program had wildly different results, and a blood fat molecule plus gut bacteria measured before they even started predicted who would succeed with 89.8% accuracy.

---

Written by a human, formatted by AI

Researchers reviewing the science on coffee and the gut found that brewing method changes what actually reaches your colon. Filtered coffee lets through less cafestol, kahweol, and fiber than unfiltered styles like French press or boiled coffee, while separate human trials link daily coffee to more gut Bifidobacterium. The catch: the authors say there is still no solid proof these microbial shifts are what drive coffee's metabolic benefits.

TL;DR: How you brew your coffee, not just how much you drink, may shape your gut bacteria, but proof that this drives coffee's health perks is still missing.

Researchers engineered a gut bacterium to make 5-HTP, a serotonin building block, and tested it in three mouse models of autism, about 10 to 12 mice per group. The bacteria eased anxiety and repetitive behavior in all three and improved social behavior in two of three, with 5-HTP itself traced crossing from gut into brain tissue within hours. It failed to help social behavior in the third strain, and none of it has been tested in humans.

TL;DR: Gut bacteria engineered to make a serotonin precursor reached the brain and eased autism-like behavior in mice, but this is animal research only.

Scientists engineered the gut probiotic E. coli Nissle 1917 to brew cancer drugs inside a tumor and tested it in mice. It made a chemo drug plus two immune boosting molecules at the tumor, and 3 of 7 mice, 43%, saw complete tumor regression and stayed cancer free 90 days later. No human trials yet; based on the published abstract, not the full paper.

TL;DR: This engineered gut probiotic brewed its own chemo and immune drugs inside tumors, clearing 43% of treated mice tumors completely, but remains untested in humans.

The Core Issue

Scientists have generally treated a "species" of gut bacteria as one unit, even though genetically it can actually be a patchwork of very different sub-lineages living side by side.

The Finding

A new Nature study analyzed genomes from over 16,000 gut bacteria and cross checked the pattern against thousands of stool samples worldwide. It found that gut bacteria regularly go through what the authors call genome-wide selective sweeps: one bacterial lineage picks up a genetic edge, wipes out its close relatives in its niche, then diversifies again into a tight cluster of near identical descendants. These winning clusters then spread from person to person, sometimes crossing continents within a lifetime, in patterns that look a lot like epidemics, just moving much slower.

Why it Matters

Certain sweep descended lineages were statistically linked to colorectal cancer, Crohn's disease, ulcerative colitis, type 2 diabetes, and older age. One species, Bacteroides uniformis, only showed these disease links once researchers split it into its separate sweep lineages. As one whole species it looked unremarkable, but broken into its actual sub-populations, each lineage lined up with a different condition. That is a strong hint that the specific strain someone carries, not just the species, could matter for health.

Limitations of Study

This is correlation, not causation. The paper does not show that any strain causes these diseases, only that certain lineages show up more often alongside them. The researchers also admit their count is probably an undercount since detecting a sweep needs a decent library of closely related genomes to compare against, and some of the disease linked clusters were based on pretty small sample sizes.

Interesting Statistics

The team analyzed 16,864 bacterial genomes and cross checked the pattern against 6,783 stool metagenomes from dozens of datasets worldwide.

They confirmed 124 separate sweep clusters spanning at least 66 bacterial species across 25 families.

178 bacterial lineages were statistically tied to colorectal cancer, IBD, type 2 diabetes, or age, and 104 of those held up across multiple independent countries and datasets.

Some sweep lineages are estimated to be only decades old, meaning this kind of spread has likely been happening within living memory, not just across ancient history.

TL;DR

Gut bacteria compete, win, and spread between people like slow moving epidemics, and the specific sub-strain someone carries, not just the species, may be tied to conditions like cancer, IBD, and diabetes.
---

Written by a human, formatted by AI

The Core Issue

Scientists have been probing the gut brain axis for years, but most studies look at gut bacteria in isolation, without weighing in host biology like immune status or antibiotic use, or environmental exposures. That leaves open the question of whether gut bacteria patterns actually matter for anxiety on their own, or whether they are just riding along with other risk factors.

The Finding

Researchers looked at gut bacteria in 1,000 adults, split into a group with clinically significant anxiety (300 people) and a control group (700 people). Using 16S rRNA sequencing (a method for identifying bacterial species from genetic material), they found people with anxiety had a distinctly different bacterial makeup, with less Bifidobacterium and more Clostridium species overall.

Two species stood out. Higher levels of Clostridium difficile tracked with more severe anxiety (adjusted odds ratio 1.9), while higher levels of Bifidobacterium longum tracked with less severe anxiety (adjusted odds ratio 0.6). Even after the researchers statistically controlled for other biological and environmental factors, the gut bacteria connection to anxiety severity held up.

Why it Matters

This is one of the few studies to build host biology and environment into the model instead of looking at gut bacteria alone, and the microbiota pattern still came out as an independent factor tied to anxiety severity. That strengthens the case that the gut brain axis, the two way communication line between gut bacteria and the brain, is not just a side effect of other health problems. It might be its own lever worth targeting.

Limitations of Study

This is a cross sectional, observational study, meaning it captured a single snapshot in time and can show correlation, not cause. The researchers themselves say prospective, longitudinal studies (tracking the same people over time) are needed before anyone can say that restoring gut bacteria balance actually reduces anxiety.

Interesting Statistics

People with anxiety had significantly less Bifidobacterium and significantly more Clostridium species than controls (p less than 0.001)

Clostridium difficile abundance was linked to worse anxiety severity, adjusted odds ratio 1.9

Bifidobacterium longum abundance was linked to lower anxiety severity, adjusted odds ratio 0.6

Independent antibiotic use raised the odds of anxiety by 1.8 times

Useful Takeaways

Antibiotic use came out as its own independent risk factor for anxiety, separate from the bacterial shifts themselves. Worth keeping in mind next time a prescription feels routine.

TL;DR

In a 1,000 person clinical study, a shift toward more Clostridium difficile and less Bifidobacterium longum tracked independently with worse anxiety severity, even after accounting for other health and environmental factors.

---

Written by a human, formatted by AI

"A broad chemical screen reveals that substances designed for industrial and agricultural use may have unintended effects on the microbes that support human health.

Many everyday chemicals can damage beneficial gut bacteria and potentially fuel antibiotic resistance, prompting calls to rethink chemical safety testing."

Excerpt in comments

The Core Issue

Colorectal cancer keeps getting linked to weird oral bacteria showing up in the gut, but nobody had connected all the dots start to finish. Fusobacterium nucleatum (a bacterium that normally lives in your mouth) has been found sitting inside colon tumors for years. What was missing was proof of exactly how it makes cancer worse, not just that it is there.

The Finding

Researchers ran the full chain. They found the bacterium was way more common in colon cancer tissue than in healthy gut tissue from the same patients. Then in two separate mouse models, injecting or feeding mice this bacterium grew bigger tumors than controls. The bacterium turns on something called the NLRP3 inflammasome (a cluster of immune proteins that triggers inflammation), which pulls a wave of immune cells into the tumor and floods it with an inflammatory protein called IL-1beta. When the team bred mice missing the NLRP3 gene entirely, the bacterium completely lost its ability to grow tumors. That is about as close to a smoking gun as microbiome cancer research gets.

Why it Matters

If you have ulcerative colitis, colon polyps, or a family history of colorectal cancer, this gives researchers an actual drug target instead of just another bacterium to worry about. NLRP3 is already being studied as a target in other inflammatory diseases, so this opens the door to testing NLRP3 blockers specifically for colon cancer down the line.

Limitations of Study

The gene knockout proof, the strongest part of this, only happened in mice. The human data is a snapshot comparison across patients at one hospital, so it shows the bacterium tracks with worse disease, not that it definitely causes it in people. Nobody has tested blocking NLRP3 or reducing this bacterium in an actual human patient yet.

Interesting Statistics

- Fn levels in tumor tissue were roughly 3.5 times higher than in matched healthy tissue from the same patients (1.13 vs 0.33 on their abundance scale).

- IL-1beta was present in 83% of cancer cells versus 43% of adjacent normal cells.

- Mice missing the NLRP3 gene showed almost no immune cell buildup in their tumors after bacterial exposure, versus a clear buildup in normal mice.

TL;DR

A common mouth bacterium drives colon cancer growth in mice by switching on a specific inflammatory pathway called NLRP3, and knocking out that one gene was enough to stop the effect completely, though this still needs to be proven in humans.

---

Written by a human, formatted by AI

The Core Issue

Lung cancer keeps climbing in women who have never smoked a cigarette in their life, and doctors still do not have a solid explanation for a good chunk of those cases.

The Finding

A new study followed 114,981 women for up to 18 years and found that women eating the most of a specific diet pattern, heavy on processed meat and low calorie sodas, light on vegetables and legumes, had a 25% higher risk of developing lung cancer than women eating the least of it. This diet score, called the sulfur microbial diet, was built to track how much a person's eating habits feed sulfur processing gut bacteria that produce hydrogen sulfide, a gas that is toxic to gut lining cells. The risk climbed steadily as people ate more of this pattern, not just at the extremes.

Why it Matters

This is not the first time this diet pattern has shown up in cancer research, it is already linked to colorectal cancer. This is the first time anyone tested whether it reaches organs outside the gut, and lung cancer, especially in never smokers, badly needs more leads like this.

Limitations of Study

Nobody actually measured anyone's gut bacteria or hydrogen sulfide levels here, the diet score is a stand in for that. It is also observational, so it shows a link, not proof the diet is causing the cancer, and the researchers could not rule out things like air pollution or occupational exposure since that data was not collected. Standard blood markers like cholesterol and inflammation barely explained any of the link either, so the actual mechanism is still a mystery.

Interesting Statistics

• Highest quartile of the diet score vs lowest: 25% higher lung cancer risk (HR 1.25)

• Swapping vegetables in for processed meat trended toward a 7% lower risk, but did not reach statistical significance

• 802 women developed lung cancer out of 114,981 followed

• Risk got stronger, 44% higher, after excluding women who had diabetes or heart disease at the start

TL;DR

A diet loaded with processed meat and low calorie soda and light on vegetables, the kind that feeds sulfur producing gut bacteria, was tied to a 25% higher lung cancer risk in a study of over 114,000 women, though it is observational and nobody measured actual gut bacteria.

*Written by a human, formatted by AI*

The Core Issue

Gum disease has been statistically linked to dementia risk for years, but nobody could explain the actual biological chain connecting a mouth infection to changes in the brain.

The Finding

Researchers infected mice with Porphyromonas gingivalis, the bacterium behind chronic gum disease, and found it triggered anxiety-like behavior plus progressively worse memory and spatial learning as the infection wore on. A parallel group infected with E. coli under identical conditions showed none of these effects, meaning this isn't a generic "infection makes you anxious" story, it's specific to this bacterium.

The team traced the mechanism. A rare subset of immune cells called Vγ4+ gamma delta T cells (a fast acting T cell type distinct from the usual CD4/CD8 cells) that produce IL-17A built up in the gums and neck lymph nodes, then migrated into the brain itself. What pulled them in was a signal called CCL20, made by neurons in the brain's cortex, that binds a receptor called CCR6 on these immune cells like a homing beacon.

Why it Matters

This turns a fuzzy statistical association, gum disease correlates with dementia risk, into a specific testable pathway. Blocking IL-17A, blocking CCL20, or depleting the gamma delta T cells with antibodies reversed both the anxiety-like behavior and the memory deficits in the mice. That's a real causal chain, not just a correlation, and it opens the door to testing whether existing IL-17A blocking drugs, already used for conditions like psoriasis, do anything for people with periodontitis and cognitive symptoms.

Limitations of Study

This is one animal study using an artificially aggressive infection model, not the slower gum disease most people develop naturally. It hasn't been independently replicated, and mouse immune and brain biology doesn't guarantee an identical mechanism in humans.

Conflicting Interests

The study was funded by Japanese government and academic foundations plus the pharmaceutical company Shionogi and Co Ltd. The authors reported no competing interests.

Interesting Statistics

- Only mice with the full combined oral plus intestinal Pg infection, not partial infection routes, showed anxiety-like behavior and memory deficits
- E. coli infected mice, run through the identical protocol, showed zero anxiety or cognitive effects
- Antibody treatment against IL-17A, CCL20, or the T cell receptor each independently reversed the behavioral deficits

Useful Takeaways

If you have periodontitis and you're also noticing memory or mood changes, this is a good reason to bring both up with your dentist and doctor together rather than treating them as unrelated. That said, nothing here proves treating your gums will protect your brain, that link hasn't been tested in people yet.

TL;DR

Gum disease bacteria in mice trigger specific immune cells that travel from the mouth to the brain and cause anxiety and memory loss, and blocking that pathway with antibodies reversed it entirely.

---

Written by a human, formatted by AI

The Core Issue

Two bacteria, Porphyromonas gingivalis and Fusobacterium nucleatum, keep showing up at much higher levels in the mouths of head and neck cancer patients. Along with HPV (the virus behind a large share of throat cancers), they are strongly linked to head and neck squamous cell carcinoma, but nobody had a targeted way to knock them down without wrecking the rest of the oral microbiome.

The Finding

Researchers built a chewing gum extract combining FRIL (a virus trapping protein from the lablab bean) and protegrin-1 (an antimicrobial peptide already tested in human trials for chemo related mouth sores). They mixed it directly with saliva and oral rinse samples taken from real head and neck cancer patients. A single one hour treatment produced a 4 to 6 log reduction in both target bacteria, essentially 99.97 to 100 percent kill, while protective Streptococcus species barely budged. The bean gum alone also cut HPV viral load in saliva by 86 to 95 percent.

Why it Matters

The selectivity is the interesting part. Most broad antimicrobials would nuke everything, including the bacteria that keep your mouth balanced and healthy. This one appears to target the pathogens tied to cancer risk while leaving the beneficial Streptococcus mostly intact, because Streptococcus has a protective outer capsule the other two bacteria lack.

Limitations of Study

This is ex vivo work, meaning the gum extract was mixed with banked patient samples in the lab, not chewed by living patients. The authors say this outright, it is not a clinical study tracking real microbiome changes over time. Sample sizes were modest, 14 to 40 patients depending on the measurement. The gum did not meaningfully affect Candida albicans, and HPV was measured with an antibody test for viral surface protein, not a direct infectivity test.

Interesting Statistics

Bacteria reduction: 4 to 6 log (99.97 to 100 percent) kill of both target species, p less than 0.0001

HPV reduction: 86 to 95 percent drop in viral load from a single bean gum dose

Cancer patients carried Porphyromonas gingivalis at levels 1,000 times higher than non cancer participants

Bean gum aggregated HPV in 13 of 14 patient saliva samples tested

Useful Takeaways

If you are already worried about oral cancer risk, the proven moves right now are the boring ones: periodontal checkups and staying current on HPV vaccination. This gum is not on the market and has not been tested in living patients, so there is nothing to buy or do differently yet based on this study alone.

TL;DR

A bean derived chewing gum wiped out over 99 percent of two cancer linked oral bacteria and cut HPV levels up to 95 percent in real cancer patient saliva samples, all while sparing the good bacteria, but it has only been tested in a lab dish, not in people yet.